Abstract
Clinical and experimental evidence suggests that, in Parkinson's disease, the late-occurring fluctuations in response to levodopa therapy are due to progression of the disease rather than to the therapy. Therefore, treatment with carbidopa/levodopa should be started early, because postponement does not provide patients with added benefits but deprives them of the most satisfying period of the therapeutic response. © 1984, Canadian Neurological Sciences Federation. All rights reserved.
Cite
CITATION STYLE
Muenter, M. D. (1984). Should Levodopa Therapy Be Started Early or Late? Canadian Journal of Neurological Sciences / Journal Canadien Des Sciences Neurologiques, 11(S1), 195–199. https://doi.org/10.1017/S0317167100046400
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.